Arthritis rheumatoideus anticancer
Mercedem:T/T, L/C
Product Origin:China
Shipping Portus:Beijing/Shanghai/Hangzhou
Facultas productio;100kg / mensis
Order(MOQ);25kg
Tempus ducere:III Days
Repono conditione:Condita in loco frigido, sicco, cella temperie.
Sarcina materia:tympanum
Sarcina amplitudo:25kg/tympanum
Salus notitia:Non periculosum bonis
Introductio
Tofacitinib, medicamentum ad arthritis tractant rheumatoidis, arthritis psoriatic, et ulcerativi colitis.
Adultis tofacitinib citratis adhibetur, cum moderate arthritis rheumatoideis activos graviter activos, qui responsionem inadaequatam habuerint, vel methotrexatam patientem.
Tofacitinib citratum indicatur curatione moderatae arthritis activi rheumatoidei (RA) in adultis, qui parum responderint, vel qui ad unam vel plura pharmaca antirheumatica morbosorum modificantia intolerantia sunt.
Specification (in domo)
| Item | Specification |
| Aspectus | Alba vel off-alba crystallina pulveris |
| Lepidium sativum | IR, HPLC |
| Aquae | ≤1.5% |
| Substantiae cognatae | TOFA 06 ≤0.15% |
| Tofacitinib trans isomer ≤0.15% | |
| Tofacitinib dehydrogenated ≤0.15% | |
| Quisque ignotus immunditiam ≤0.10% | |
| Totalis immunditias: ≤1.0% | |
| RELICTUM Solvents | Ethanol ≤5000ppm |
| Benzene ≤2ppm | |
| Toluene ≤890ppm | |
| Chloroethane ≤1000ppm | |
| N,N-Dimethylformamide ≤800ppm | |
| Palladium ≤10ppm | |
| Dichloromethane ≤600ppm | |
| Cinis sulphated | ≤0.1% |
| Grave metallum | ≤10ppm |
| Chrial HPLC | 3S, 4S tofacitinib ≤0.15% |
| Pertentare (ex anhydrous basi) 98.0-102.0% |
